Dr. Margot Morssinkhof

PostDoc researcher @AmsterdamUMC | Neuroscientist | Studies sex hormones, depression and sleep 🧠🏳️‍🌈😴 | She/Her | PhD |

[Dr. Margot Morssinkhof @HormonoGo]

Thanks to the Amsterdam University Fund, and many thanks to my colleagues, supervisors and @NederlandPMDD for their valuable input. I'm really excited about starting this project!

Do you have good ideas, input or want to know more about the TIDE project? Do let me know 📩!

[Dr. Margot Morssinkhof @HormonoGo]

I am very excited to have received an Amsterdam UMC Startstipendium grant! With this grant, I will set up a new study on premenstrual exacerbation (PME) in depression: the TIDE project.

A short thread on PME and the project 🧵:

[Dr. Margot Morssinkhof @HormonoGo]

With the TIDE project, I hope we can gain a better understanding of how many people with depression suffer from premenstrual exacerbation of their symptoms. We will also study whether it is clinically relevant for treatment providers to do daily symptom tracking across the cycle.

[David Matthew Doyle @DavidMDoyle]

So proud of our symposium yesterday at @wpath on psychosocial and social health outcomes after gender-affirming hormones. Amazing presentations from @NessaMillet1 @HormonoGo from @AffirmRelation and @DrBrendanNolan1. This work is so important to healthcare equity for trans people

[Dr. Margot Morssinkhof @HormonoGo]

@nifti12 @ERC_Research Congratulations, that's amazing 🥳🥳🥳!!

[Dr. Margot Morssinkhof @HormonoGo]

@AM_Doornweerd Ahh very cool study, congrats on the preprint! 🥳

[Dr. Margot Morssinkhof @HormonoGo]

This study was partially intended as a pilot study for the work we will do in the Affirm Relationships project, in which we will study social and psychological well-being using more diary-style and EMA measuremements. Make sure to follow @AffirmRelation to stay up to date 📣!

[Dr. Margot Morssinkhof @HormonoGo]

We measured variability through calculation of the iSD, meaning the within-measurement SD of the day-to-day affect outcomes. As shown below, participants with the same mean affect level can show large differences in affect variability when assessing the iSD.

[Dr. Margot Morssinkhof @HormonoGo]

Since we're still in the preprint phase, let us know if you have any thoughts on the study! Happy to talk about any improvements we could make in the manuscript 💡.

[Dr. Margot Morssinkhof @HormonoGo]

In the RESTED study, we asked participants to complete daily diaries, which included items on negative mood. Using these items, we assessed whether day-to-day variability in reported negative affect showed changes after 3 and 12 months of gender-affirming hormones.

[Dr. Margot Morssinkhof @HormonoGo]

NEW PREPRINT! 🥳
I’m very excited about our new preprint, in which we report on changes in affect variability in transgender people starting gender-affirming hormones:
https://t.co/h67jJQGIgI

A short thread on our study setup and results below 🧵:

[Dr. Margot Morssinkhof @HormonoGo]

Affect variability is the degree to which our emotions fluctuate over time. Trans people have reported changes in emotionality after starting gender-affirming hormones, including “flattening” of emotions after masculinizing hormones and deeper emotions after feminizing hormones.

[Dr. Margot Morssinkhof @HormonoGo]

@NessaMillet1 @amsterdamumc Happy Amsterdammiversary, so happy to have you here🫶🏻✨️!

[Dr. Margot Morssinkhof @HormonoGo]

With warm thanks to my supervisors and opponents for the time and attention dedicated to my thesis and defense!

[Dr. Margot Morssinkhof @HormonoGo]

PhDone! After defending my thesis yesterday, I'm officially going by Dr. Margot now 👩🏼‍🎓🥹

[Dr. Margot Morssinkhof @HormonoGo]

I had the best day, thanks to sweet friends, family and colleagues who spoiled me with the coolest personal gifts 🫶🏻